• Sodium Oxamate: Practical LDH-A Workflows

  2026-08-19

  Sodium Oxamate enables controlled disruption of lactate production without introducing DMSO or ethanol into aqueous assays. This guide translates a neuroinflammation study into practical metabolic, lactylation, cancer-cell, and white-matter injury workflows, with numeric starting conditions and troubleshooting guidance.

• Perphenazine: D2 Antagonist Research Guide

  2026-08-18

  Perphenazine is a dopamine D2 receptor antagonist with a broader phenothiazine receptor binding profile. Research data support its use in schizophrenia research, mitochondria-mediated cell death induction, opioid tolerance suppression models, and emerging host-directed antibacterial studies.

• SAR405: Selective Vps34 Inhibitor for Autophagy

  2026-08-18

  SAR405 is a potent, selective Vps34 inhibitor that blocks ATP-dependent class III PI3K activity and PtdIns3P production. Its nanomolar biochemical potency and defined effects on autophagy, vesicle trafficking, and lysosome function make it a useful research tool rather than a standalone indicator of clinical efficacy.

• Tariquidar: Mechanobiology of P-gp Chemoresistance

  2026-08-17

  A high-viscosity tumor microenvironment can increase P-glycoprotein through TRPV4–YAP mechanotransduction, creating a new experimental context for Tariquidar (XR9576). This article shows how selective transporter inhibition can help translational researchers distinguish mechanical regulation of drug resistance from downstream drug efflux.

• Minocycline HCl for Microglial Assays

  2026-08-17

  Minocycline HCl provides a practical pharmacological control for testing whether microglial activity drives retinal amyloid clearance and inflammatory outcomes. This workflow translates 40-Hz flicker findings into reproducible assay design, with preparation guidance, causal controls, and troubleshooting for retinal and neurodegenerative models.

• Alfuzosin Hydrochloride for Reliable Cell Assays

  2026-08-16

  This scenario-based guide explains how Alfuzosin Hydrochloride, SKU A5173, can be incorporated into receptor-focused, viability, proliferation, and cytotoxicity workflows. It connects mechanism, solution preparation, analytical calibration, data interpretation, and vendor selection while distinguishing documented product properties from assay-specific variables that require local validation.

• Camptothecin Workflows for DNA Damage Research

  2026-08-15

  Build reproducible DNA damage, cell-death, autophagy, and adaptive-evolution assays with Camptothecin, a mechanistically defined topoisomerase I inhibitor. This guide connects dose-and-time optimization in cancer models with experimental-evolution concepts from recent prion research while clearly separating established evidence from hypothesis-driven applications.

• Metal-Free Carbon Nanozymes for Sensitive ALP Detection

  2026-08-15

  The reference study develops a metal-free carbon-dot nanozyme assay that converts alkaline phosphatase activity into a colorimetric turn-on signal through pyrophosphate inhibition and enzymatic hydrolysis. Its kinetic analysis shows that pyrophosphate binds at a site distinct from the principal catalytic site, supporting sensitive ALP measurement while reducing metal-related interference.

• RAB Proximity Maps Reveal RAB14 Endosomal Roles

  2026-08-14

  This Communications Biology study uses APEX2 proximity labeling to map proteins neighboring 23 human RAB GTPases, addressing the transient and context-dependent nature of RAB interactions. The dataset identifies functional links involving RAB25, RAB14, the EARP complex, SHIP164, and UHRF1BP1, providing a resource for studying endosomal trafficking and candidate effector recruitment.

• From HBV Entry Biology to Capture Strategy

  2026-08-14

  The CDC42–Rab11–NTCP axis reframes hepatitis B virus entry as a trafficking problem with parallel internalization routes. This thought-leadership article shows how Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) can support translational assays that connect biotinylated molecule capture with mechanistic validation, while clearly distinguishing assay enablement from therapeutic proof.

• Rotigotine Hydrochloride: Receptor Biology to Translation

  2026-08-13

  Rotigotine hydrochloride is more than a symptomatic dopaminergic tool: its D2/D3 full agonism, broader receptor activity, neuroprotective profile, and formulation sensitivity create a powerful framework for translational Parkinson’s disease research. This article connects receptor pharmacology, experimental design, analytical quality, and clinical relevance.

• Mitomycin C: Mechanism and Cancer Research Uses

  2026-08-13

  Mitomycin C is an antitumor antibiotic and DNA synthesis inhibitor used in cancer research. Its covalent DNA-adduct mechanism supports proliferation studies, while supplier-reported TRAIL-sensitization data define a useful apoptosis signaling research model.

• Rotigotine Hydrochloride: From Receptor to Translation

  2026-08-12

  A translational framework for using Rotigotine hydrochloride to connect dopamine-receptor pharmacology, continuous delivery, disease modeling, and clinically relevant outcome design in Parkinson’s disease and restless legs syndrome research.

• CBD Mechanisms in Orofacial Inflammatory Pain

  2026-08-12

  The reference study shows that cannabidiol (CBD) acts across peripheral and central endocannabinoid pathways to reduce inflammatory pain, pain-related affective disturbances, and cognitive deficits in mice. Its value lies in linking FAAH regulation, CB2- and CB1-dependent signaling, inflammatory mediators, and central amygdala serotonin activity within a multidimensional pain framework.

• Gut–Brain Cholinergic Signaling in Seizure Control

  2026-08-11

  Jia et al. identify a gut–vagus–brain cholinergic circuit through which Bacteroides fragilis suppresses seizures, linking colonic ChAT-positive cells, vagal transmission, and intestinal Lactobacillus enrichment. Integrated mouse experiments and a randomized pediatric clinical trial provide both mechanistic and translational evidence for microbiota-targeted strategies in refractory epilepsy.

445 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page